Portage Biotech (PRTG) Institutional Ownership $8.47 -0.21 (-2.42%) Closing price 04:00 PM EasternExtended Trading$8.37 -0.10 (-1.18%) As of 04:16 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisChartCompetitorsEarningsFDA EventsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Portage Biotech (NASDAQ:PRTG)CurrentInstitutional OwnershipPercentage13.36%Number ofInstitutional Buyers(last 12 months)3TotalInstitutional Inflows(last 12 months)$1.42MNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$409.72K Get PRTG Insider Trade Alerts Want to know when executives and insiders are buying or selling Portage Biotech stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data PRTG Institutional Buying and Selling by Quarter Portage Biotech Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/17/2025 Citadel Advisors LLC15,431$80K0.0%N/A1.470% 2/14/2025Bison Wealth LLC19,272$100K0.0%-80.4%1.837% 11/20/2024 Virtu Financial LLC10,919$73K0.0%N/A1.041% 9/5/2024Sanctuary Advisors LLC297,728$63K0.0%N/A28.355% 8/15/2024 Armistice Capital LLC1,501,780$319K0.0%-9.9%8.437% 2/13/2024 Armistice Capital LLC1,876,105$3.42M0.0%-4.7%10.540% 11/15/2023 Armistice Capital LLC1,968,105$4.11M0.1%N/A11.056% 8/14/2023Bison Wealth LLC213,398$746K0.1%N/A1.199% 8/8/2023 Ieq Capital LLC16,650$58K0.0%N/A0.094% 5/10/2023 MAI Capital Management78,676$243K0.0%+36.8%0.464% Get the Latest News and Ratings for PRTG and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Portage Biotech and its competitors with MarketBeat's FREE daily newsletter. 2/9/2023 MAI Capital Management57,512$304K0.0%N/A0.340% 11/14/2022Ergoteles LLC20,597$140K0.0%-11.6%0.122% 7/21/2022 Beacon Investment Advisory Services Inc.11,395$80K0.0%N/A0.085% 5/2/2022 Allspring Global Investments Holdings LLC8,189$53K0.0%N/A0.061% 4/20/2022 Sigma Planning Corp11,388$75K0.0%N/A0.085% 2/14/2022 Maven Securities LTD131,832$1.42M0.0%-41.3%0.989% 2/4/2022 Beacon Investment Advisory Services Inc.11,395$122K0.0%N/A0.086% 11/9/2021BlackRock Inc.213,123$4.33M0.0%+19.7%1.599% 11/4/2021 Deutsche Bank AG2,875$58K0.0%+34.3%0.022% 8/18/2021 Blackstone Inc65,000$1.36M0.0%N/A0.488% 8/16/2021 Blackstone Inc65,000$1.36M0.0%N/A0.488% 8/16/2021 California State Teachers Retirement System5,050$106K0.0%N/A0.038% 8/16/2021 Maven Securities LTD278,694$6.33M0.3%N/A2.091% 8/16/2021 State Street Corp46,453$974K0.0%N/A0.349% 8/13/2021 Northern Trust Corp44,634$935K0.0%N/A0.335% 8/13/2021 Altium Capital Management LP75,000$1.57M0.4%N/A0.563% 8/13/2021 Geode Capital Management LLC35,039$734K0.0%N/A0.263% 8/13/2021 Vanguard Group Inc.13,107$275K0.0%N/A0.098% 8/12/2021 JPMorgan Chase & Co.4,746$99K0.0%N/A0.036% 8/12/2021 Monashee Investment Management LLC110,000$2.31M0.3%N/A0.825% 8/11/2021BlackRock Inc.178,027$3.73M0.0%N/A1.336% 8/11/2021 Deutsche Bank AG2,140$45K0.0%N/A0.016% 8/2/2021 New York State Common Retirement Fund3,900$82K0.0%N/A0.032% (Data available from 1/1/2016 forward) PRTG Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of PRTG shares? During the previous two years, the following institutional investors and hedge funds held shares of Portage Biotech shares: Armistice Capital LLC ($319K), Bison Wealth LLC ($100K), Citadel Advisors LLC ($80K), and Virtu Financial LLC ($73K), Sanctuary Advisors LLC ($63K).Learn more on Portage Biotech's institutional investors. What percentage of Portage Biotech's stock is owned by institutional investors? 13.36% of Portage Biotech's stock is owned by institutional investors. Learn more on PRTG's institutional investor holdings. Which institutional investors have been buying Portage Biotech's stock? The following institutional investors have purchased Portage Biotech's stock in the last 24 months: Armistice Capital LLC ($1.97M), Sanctuary Advisors LLC ($297.73K), Citadel Advisors LLC ($15.43K), and Virtu Financial LLC ($10.92K). How much institutional buying is happening at Portage Biotech? Institutional investors have bought a total of 324,078 shares in the last 24 months. This purchase volume represents approximately $1.42M in transactions. Which of Portage Biotech's major shareholders have been selling company stock? The following institutional investors have sold Portage Biotech stock in the last 24 months: Bison Wealth LLC ($79.25K). How much institutional selling is happening at Portage Biotech? Institutional investors have sold a total of 79,249 shares in the last 24 months. This volume of shares sold represents approximately $409.72K in transactions. Related Companies Pluri Major Shareholders CalciMedica Major Shareholders Karyopharm Therapeutics Major Shareholders PepGen Major Shareholders SCYNEXIS Major Shareholders Equillium Major Shareholders Iterum Therapeutics Major Shareholders Clearside Biomedical Major Shareholders Rani Therapeutics Major Shareholders Akari Therapeutics Major Shareholders This page (NASDAQ:PRTG) was last updated on 8/18/2025 by MarketBeat.com Staff From Our PartnersBiotech Alert: With news on MPox, RSV, and more, this tiny firm could disrupt a $3B marketA small biotech is stepping into the spotlight with a first-in-class antiviral platform—and it could be one of...Smallcaps Daily | SponsoredFormer CIA Officer Reveals How Gold Saved His Life This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredThe stealth altcoin the financial world is underestimatingThis DeFi project could soar next When altcoin season fully kicks in—which the data suggests is happening R...Crypto 101 Media | SponsoredNew law could create $3.7 trillion tsunami.During a meeting in Washington D.C., Jeff Brown discovered a bold initiative. He calls it “President Trump’...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Portage Biotech Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Portage Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access